$AUPH
Aurinia Pharmaceuticals Inc
PRICE
$11.39 β²13.333%
Last Close
VOLUME
4,859,753
DAY RANGE
9.86 - 11.47
52 WEEK
8.86 - 33.97
Key Metrics
Market Cap
1.61 B
Beta
1.69
Avg. Volume
3.60 M
Shares Outstanding
141.74 M
Yield
0%
Public Float
0
Next Earnings Date
2022-08-04
Next Dividend Date
Company Information
Aurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. The Companyβs head office is in Victoria, British Columbia, its U.S. commercial hub is in Rockville, Maryland, and the Company focuses its development efforts globally.
CEO: Peter Greenleaf
Website: www.auriniapharma.com
HQ: 1203-4464 Markham St Victoria, V8Z 7X8 British Columbia
Related News